Clinical Trial Results:
An eight-week, randomized, double-blind, multi-center, active-controlled, parallel group study to evaluate the safety and efficacy of an aliskiren based regimen compared to a lisinopril based regimen in patients with uncomplicated severe hypertension
Summary
|
|
EudraCT number |
2004-001060-50 |
Trial protocol |
HU ES |
Global completion date |
25 Nov 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Feb 2017
|
First version publication date |
15 Feb 2017
|
Other versions |
|
Summary report(s) |
CSPP100A2303_NovCTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.